Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Phthalazine derivatives as PARP inhibitors

Phthalazine derivatives as PARP inhibitors

US Patent 8946221 · Granted Feb 3, 2015

Estimated economic value: $109,542,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

HPK1 inhibitors2025
Bicyclic HPK1 inhibitors2025
Bicyclic pyridine, pyrazine, and pyrimidine derivatives as PI3K beta inhibitors2021
Pyrazolyl quinoxaline kinase inhibitors2019
Substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrimidine derivatives and 2,3-dih2019
Substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrazine derivatives and 5,6,7,8-t2019
Heterocyclyl linked imidazopyridazine derivatives as PI3KB inhibitors2019
Quinazolinone derivatives as PARP inhibitors2018
Quinazolinone derivatives as PARP inhibitors2018
Quinazolinone derivatives as PARP inhibitors2018
Quinazolinone derivatives as PARP inhibitors2018
Quinazolinone derivatives as PARP inhibitors2018